Research reveals how blood flow force protects blood vessels

Jan 28, 2010

It is second nature for most of us that exercise protects against heart attack and stroke, but researchers have spent 30 years unraveling the biochemistry behind the idea. One answer first offered by researchers at the University of Rochester Medical Center is that athletic hearts push blood through arteries with greater force, which alone triggers reactions that protect against dangerous clogs in blood vessels.

In the latest study out of Rochester, published recently in the journal Blood, researchers demonstrated that they are very close to understanding every step in one flow-sensitive that protects arteries. Each step provides an opportunity to mimic with drugs the proven ability of fast, steady to open up blood vessels and avert the inflammation and that come with atherosclerosis.

Past research at the Medical Center and elsewhere had determined that two genes, Krüppel-like factor 2 (KLF2) and endothelial nitric oxide synthase (eNOS), are turned on by blood flow force to reverse atherosclerosis, but not how. The current study found for the first time that flow causes a structural change in the enzyme histone deacetylase 5 (HDAC5), which in turn influences whether the two key genes are turned on.

"Obviously we should all be exercising to get our hearts pumping fast, which increases blood flow force through our vessels with all of these molecular benefits," said Zheng-Gen Jin, Ph.D., associate professor of Medicine within the Aab Cardiovascular Research Institute (CVRI) at the University of Rochester Medical Center, and corresponding author for the study. "Beyond that, the designers of future therapies may manipulate HDAC5 to fine-tune the action of protective genes."

Forcing It

The current study revolves around a signaling process called phosphorylation, in which enzymes called kinases attach a set of molecules called a phosphate group to a target to switch life processes on or off. In cells lining blood vessels (endothelial cells), the attachment of a phosphate group to an HDAC5 kicks it out of the cell's nucleus, perhaps by hiding a label that says it belongs there.

To study whether blood flow force represents one the signals that cause HDAC5 nuclear export, the team designed a virus to invade the cells and swap out the key building blocks that make possible its phosphorylation via blood flow force. Weiye Wang, also a member of the CVRI and first author of the paper, designed the virus. He also attached a fluorescent tag to HDAC5 in the mutated cells so the team could track it as it moved.

What the team found for the first time is that blood flow force (also called sheer stress) does indeed cause the phoshorylation, and export from the nucleus, of HDAC5 in endothelial cells. Importantly, the team also found that flow, by removing HDAC5 from the scene, forces it to break away from the molecule it usually attaches to in the nucleus: myocyte enhancer factor-2 (MEF2).

When free, MEF2 is known to drive the expression of Krüppel-like factor 2, which calls for increases in the supply of endothelial nitric oxide synthase (eNOS). eNOS then builds more of the that tells muscles surrounding arteries to relax, which increases blood flow and lowers blood pressure. When cells were engineered with HDAC5 incapable of being phosphorylated by flow, HDAC5 never left the nucleus, remained stuck to MEF2 and completely blocked the expression of KLF2 and eNOS.

Furthermore, taking away the ability of fast, steady flow to phosphorylate HDAC5 greatly weakened a second lifesaving benefit of flow: it prevents white blood cells from sticking to the cells lining blood vessels, an early, necessary step in the development of atherosclerosis. Fatty diets cause cholesterol deposits to build up within arterial walls, deposits that white blood cells "see" as infections and home in on to drive inflammatory disease. By increasing KLF2 expression, blood flow force is believed to prevent adhesion molecules on cells lining arteries from snagging white blood cells as they float by.

The team also showed through a series of experiments that flow-induced HDAC5 phosphorylation depends on the well known calcium/calmodulin pathway. The team theorizes that the force of flow changes the shape of calcium channels on the surface of endothelial cells, which enables calcium to rush into the cells and turn on calmodulin, which attaches to an as yet unidentified kinase that phosphorylates HDAC5.

Identifying such an enzyme would complete the first diagram of a flow-sensitive, protective signaling pathway. Jin's lab has zeroed in on calmodulin-dependent kinases as likely suspects, and is designing experiments that will shut down the genes coding for them to see if that stops the of HDAC5 by flow. Should that be the case, the team will seek to screen for drug candidates that encourage the action of these enzymes.

Along with Jin and Wang, the effort was led at the Aab CVRI by Chang Hoon Ha, Bong Sook Jhun and Chelsea Wong. Mukesh Jain led a partnering effort at the Case Western Reserve University School of Medicine. Much of the early work in area was done in the labs of Bradford Berk, M.D., Ph.D., CEO of the University of Rochester Medical Center, and Jun-ichi Abe, M.D., Ph.D., associate professor within the Aab CVRI. Funding for the work of Jin's team came from the American Heart Association, the American Diabetes Association and the National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health. The article was published online on Dec. 30, 2009.

"If we could free MEF2 from HDAC5 with a drug, we could mimic flow force to enhance KLF2 and eNOS expression and reverse inflammation in vessel walls," Jin said. "That promises to be extremely useful, and potentially to stave off disease underway in the of humans."

Explore further: Study finds enzyme inhibitors suppress herpes simplex virus replication

add to favorites email to friend print save as pdf

Related Stories

Study details how diabetes drives atherosclerosis

Mar 13, 2008

Researchers have discovered how diabetes, by driving inflammation and slowing blood flow, dramatically accelerates atherosclerosis, according to research to be published in the March 14 edition of the journal Circulation Re ...

How blood flow dictates gene expression

Dec 20, 2006

Researchers at the University of Pennsylvania School of Medicine have pinpointed a key regulatory protein that translates blood flow into gene expression. The investigators showed that in a model of mouse embryonic ...

Research uncovers new steps on pathway to enlarged heart

Oct 23, 2008

Researchers have new insight into the mechanisms that underlie a pathological increase in the size of the heart. The research, published by Cell Press in the October 24th issue of the journal Molecular Cell, may lead to the ...

Protein identified that plays role in blood flow

Sep 18, 2008

For years, researchers have known that high blood pressure causes blood vessels to contract and low blood pressure causes blood vessels to relax. Until recently, however, researchers did not have the tools to determine the ...

New therapy could preserve vessel function after heart attack

Sep 10, 2007

Scientists have identified the process that causes blood vessels to constrict during and after a heart attack. They've also demonstrated that delivering a vital molecule that is depleted during this process directly to those ...

Enzyme regulates brain pathology induced by cocaine, stress

Nov 08, 2007

Researchers have uncovered a key genetic switch that chronic cocaine or stress influences to cause the brain to descend into a pathological state. In studies with mice they showed how chronic cocaine changes gene activity ...

Recommended for you

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.